Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001213900-21-025190
Filing Date
2021-05-07
Accepted
2021-05-07 17:20:06
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE REVISED PROXY STATEMENT ea140540-defr14a_hoththerape.htm DEFR14A 443710
2 GRAPHIC image_001.jpg GRAPHIC 9270
3 GRAPHIC proxy_001.jpg GRAPHIC 288951
4 GRAPHIC proxy_002.jpg GRAPHIC 273586
5 GRAPHIC notice_001.jpg GRAPHIC 391056
6 GRAPHIC notice_002.jpg GRAPHIC 326214
  Complete submission text file 0001213900-21-025190.txt   2220003
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-38803 | Film No.: 21904041
SIC: 2834 Pharmaceutical Preparations